Skip to main content

Safety LTFU, Pts Receiving CD19 Directed CAR T-Cell Therapy clinical trials at UCSF
1 in progress, 1 open to new patients

  • CD19 CART Long Term Follow Up (LTFU) Study

    Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CD19 directed CAR T-cells (CD19 CART) for 15 years following last CD19 CART (e.g. CTL019) infusion to assess the risk of delayed adverse events (AEs), monitor for replication competent lentivirus (RCL) and assess long-term efficacy, including vector persistence.

    San Francisco, California and other locations